GTx, Inc. Announces Podium Presentation of SARM Preclinical and Clinical Trial Data at Endocrine Society's 2007 Annual Meeting

MEMPHIS, Tenn.--(BUSINESS WIRE)--GTx, Inc., (Nasdaq: GTXI) announced today that James T. Dalton, PhD, Vice President of Preclinical Research and Development at GTx, has been invited by the Endocrine Society to deliver a podium presentation on the discovery, clinical development, and therapeutic potential of selective androgen receptor modulators (SARMs) at the 2007 Annual Meeting of the Endocrine Society at the Metro Center in Toronto, Canada.